A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer

Title
A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer
Authors
Keywords
-
Journal
CANCER
Volume 117, Issue 3, Pages 526-533
Publisher
Wiley
Online
2010-09-22
DOI
10.1002/cncr.25421

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started